Activation of Complement Pathways after Contusion-Induced Spinal Cord Injury

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neurotrauma

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/neu.2004.21.1831PMID 15684772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of Complement Inhibitors in Association with Vulnerable Cells following Contusion-Induced Spinal Cord Injury

  2005cited by this paper
• Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro

  2004cited by this paper
• The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro

  2004cited by this paper
• Central Nervous System–Targeted Complement Inhibition Mediates Neuroprotection after Closed Head Injury in Transgenic Mice

  2003cited by this paper
• The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury1

  2002cited by this paper
• Efficacy of methylprednisolone therapy for the injured rat spinal cord

  2002cited by this paper
• Differing Views on Spinal Cord Repair

  2002cited by this paper
• Vaccinia Virus Complement Control Protein Enhances Functional Recovery after Traumatic Brain Injury

  2002cited by this paper
• A neutrophil elastase inhibitor (ONO‐5046) reduces neurologic damage after spinal cord injury in rats

  2001cited by this paper
• Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens

  2001cited by this paper
• Intrathecal Levels of Complement-Derived Soluble Membrane Attack Complex (sC5b-9) Correlate with Blood–Brain Barrier Dysfunction in Patients with Traumatic Brain Injury

  2001cited by this paper
• C5b-9 Terminal Complement Complex Protects Oligodendrocytes from Death by Regulating Bad Through Phosphatidylinositol 3-Kinase/Akt Pathway1

  2001cited by this paper
• IL-1 Receptor Antagonist Prevents Apoptosis and Caspase-3 Activation after Spinal Cord Injury

  2001cited by this paper
• Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.

  2001cited by this paper
• Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse

  2000cited by this paper
• Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis

  2000cited by this paper
• Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury.

  2000cited by this paper
• Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.

  2000cited by this paper
• Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice.

  2000cited by this paper
• Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat

  2000cited by this paper
• Inhibition of Complement as a Therapeutic Approach in Inflammatory Central Nervous System (CNS) Disease

  1999cited by this paper
• Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.

  1999cited by this paper
• Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury.

  1999cited by this paper
• Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury.

  1999cited by this paper
• Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

  1999cited by this paper
• Systemically Administered Interleukin-10 Reduces Tumor Necrosis Factor-Alpha Production and Significantly Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats

  1999cited by this paper
• Sublytic Terminal Complement Complexes Decrease POGene Expression in Schwann Cells

  1999cited by this paper
• The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration.

  1999cited by this paper
• Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.

  1999cited by this paper
• Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

  1999cited by this paper
• Long‐term effects of methylprednisolone following transection of adult rat spinal cord

  1999cited by this paper
• Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin

  1998cited by this paper
• Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection

  1998cited by this paper
• Regeneration of brainstem-spinal axons after lesion and immunological disruption of myelin in adult rat.

  1998cited by this paper
• Therapeutic inhibition of the complement system.

  1998influential reference
• CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury.

  1998cited by this paper
• Acute inflammatory response in spinal cord following impact injury.

  1998influential reference
• Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination

  1998cited by this paper
• Binding of complement component C1q to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation

  1998cited by this paper
• Spinal cord injury in the rat.

  1998cited by this paper
• Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis.

  1998cited by this paper
• Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.

  1998cited by this paper
• A quantifiable model of axonal regeneration in the demyelinated adult rat spinal cord.

  1998cited by this paper
• The role of the complement system in traumatic brain injury.

  1998cited by this paper
• Complement Depletion Reduces Macrophage Infiltration and Activation during Wallerian Degeneration and Axonal Regeneration

  1998cited by this paper
• C1q--how many functions? How many receptors?

  1998cited by this paper
• Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis.

  1998influential reference
• Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats

  1998cited by this paper
• Complement depletion improves neurological function in cerebral ischemia.

  1998cited by this paper
• A neuronal C5a receptor and an associated apoptotic signal transduction pathway

  1998cited by this paper
• Neuronal protection of oligodendrocytes from antibody‐independent complement lysis

  1998cited by this paper
• A Role for Complement in Phagocytosis of Myelin

  1997cited by this paper
• Characterization of neuronal cell death induced by complement activation.

  1997cited by this paper
• Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury.

  1997cited by this paper
• Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

  1997cited by this paper
• Neuronal cell death in the ischemic spinal cord: the effect of methylprednisolone.

  1997cited by this paper
• Cellular inflammatory response after spinal cord injury in sprague‐dawley and lewis rats

  1997influential reference
• Expression of Pro‐Inflammatory Cytokine and Chemokine mRNA Upon Experimental Spinal Cord Injury in Mouse: an In Situ Hybridization Study

  1997influential reference
• Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation

  1997cited by this paper
• Permeability of the blood-brain and blood-spinal cord barriers to interferons.

  1997cited by this paper
• Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion.

  1997cited by this paper
• Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease.

  1997cited by this paper
• Complement activation in the central nervous system following blood–brain barrier damage in man

  1996cited by this paper
• Expression of the APC tumor suppressor protein in oligodendroglia

  1996cited by this paper
• Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis.

  1996cited by this paper
• DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay

  1996cited by this paper
• A new method of quantifying the extent of tissue loss following spinal cord injury in the rat.

  1996cited by this paper
• CD59 expression and complement susceptibility of human neuronal cell line (NTera2)

  1996cited by this paper
• Perforant path transection induces complement C9 deposition in hippocampus.

  1996cited by this paper
• Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents

  1996cited by this paper
• Complement and clusterin in the injured nervous system.

  1996cited by this paper
• Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat.

  1996cited by this paper
• Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord.

  1996cited by this paper
• Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

  1996cited by this paper
• A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury.

  1996cited by this paper
• Sublytic complement attack induces cell cycle in oligodendrocytes.

  1996cited by this paper
• The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.

  1996cited by this paper
• A quantitative spatial analysis of the blood-spinal cord barrier. II. Permeability after intraspinal fetal transplantation.

  1996cited by this paper
• Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat.

  1995cited by this paper
• Complement-mediated neurotoxicity is regulated by homologous restriction.

  1995cited by this paper
• Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats.

  1995cited by this paper
• Physiology and pathophysiology of complement: progress and trends.

  1995influential reference
• The neuroprotective effect of high-dose methylprednisolone in rat spinal cord hemisection.

  1995cited by this paper
• Physiology and Pathophysiology of Complement: Progress and Trends

  1995cited by this paper
• Systemic cytokine administration can affect blood-brain barrier permeability in the rat.

  1995cited by this paper
• Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines.

  1995influential reference
• Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat.

  1995cited by this paper
• Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro.

  1994cited by this paper
• Secondary Cell Death and the Inflammatory Reaction After Dorsal Hemisection of the Rat Spinal Cord

  1994influential reference
• Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

  1994cited by this paper
• Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage.

  1994cited by this paper
• Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis.

  1994cited by this paper
• The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats.

  1994cited by this paper
• Odor-induced increases in c-fos mRNA expression reveal an anatomical "unit" for odor processing in olfactory bulb.

  1993cited by this paper
• Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes.

  1993cited by this paper
• Complement C1qB and C4 mRNAs responses to lesioning in rat brain.

  1992cited by this paper
• Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord

  1990cited by this paper
• Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.

  1989cited by this paper
• Reversible injury of cultured rat oligodendrocytes by complement.

  1989cited by this paper
• Distribution and time course of protein extravasation in the rat spinal cord after contusive injury.

  1989cited by this paper

• Pre-treated Mesenchymal Stem Cell-Derived Exosomes: A New Perspective for Accelerating Spinal Cord Injury Repair.

  2025cites this paper
• C1q drives neural stem cell quiescence by regulating cell cycle and metabolism through BAI1

  2025cites this paper
• Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord

  2025cites this paper
• Cannabidiol/tetrahydrocannabinol-enrich extract decreases neuroinfalmmation and improves locomotor outcome following spinal cord injury.

  2025cites this paper
• Complement-dependent neuroinflammation in spinal cord injury: from pathology to therapeutic implications

  2024cites this paper
• A review focuses on a neglected and controversial component of SCI: myelin debris

  2024cites this paper
• Microglial CD11b Knockout Contributes to Axonal Debris Clearance and Axonal Degradation Attenuation via IGF-1 After Acute Optic Nerve Injury

  2023cites this paper
• Regenerative Effects of Exosomes-Derived MSCs: An Overview on Spinal Cord Injury Experimental Studies

  2023cites this paper
• Identification of Differentially Expressed Proteins in Rats with Early Subacute Spinal Cord Injury Using an iTRAQ-based Quantitative Analysis.

  2023cites this paper
• Neuroinflammation, Microglia and Implications for Retinal Ganglion Cell Survival and Axon Regeneration in Traumatic Optic Neuropathy

  2022cites this paper
• Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell–Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury

  2022cites this paper
• Rethinking the Body in the Brain after Spinal Cord Injury

  2022cites this paper
• An “Outside-In” and “Inside-Out” Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases

  2021influential citation
• The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain

  2021cites this paper
• Inflammatory Response to Spinal Cord Injury and Its Treatment.

  2021cites this paper
• The alarmin interleukin-1α triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injury

  2021cites this paper
• Therapeutic Effect of BDNF-Overexpressing Human Neural Stem Cells (F3.BDNF) in a Contusion Model of Spinal Cord Injury in Rats

  2021cites this paper
• Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury

  2021cites this paper
• Aberrant Complement System Activation in Neurological Disorders

  2021cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury

  2021cites this paper
• Myelin, cPLA2, and Azithromycin: Modulation of Macrophage Activation in Spinal Cord Injury Inflammation

  2021cites this paper
• Retinal Ganglion Cell Axon Regeneration Requires Complement and Myeloid Cell Activity within the Optic Nerve

  2021cites this paper
• Complement in neurological disorders and emerging complement-targeted therapeutics

  2020cites this paper
• Mesenchymal Stem Cell-Derived Exosomes: Hope for Spinal Cord Injury Repair

  2020cites this paper
• Isobaric Tagging for Relative and Absolute Protein Quantification (iTRAQ)-Based Quantitative Proteomics Analysis of Differentially Expressed Proteins 1 Week After Spinal Cord Injury in a Rat Model

  2020cites this paper
• Administration of C5a Receptor Antagonist Improves the E�cacy of Human iPSCS-derived NS/PC Transplantation in the Acute Phase Of spinal Cord Injury

  2020cites this paper
• Complement C6 deficiency exacerbates pathophysiology after spinal cord injury

  2020cites this paper
• Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair

  2020cites this paper
• Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Inhibit Complement Activation In Rats With Spinal Cord Injury

  2019cites this paper
• Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System

  2019cites this paper
• DDDT_A_209636 3693..3704

  2019cites this paper
• Complement dysregulation in the central nervous system during development and disease.

  2019cites this paper
• Level-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord Injury

  2018cites this paper
• Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury

  2018cites this paper
• Cell cycle and complement inhibitors may be specific for treatment of spinal cord injury in aged and young mice: transcriptomic analyses

  2018cites this paper
• Pathophysiology of Traumatic Spinal Cord Injury

  2017cites this paper
• Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss

  2017cites this paper
• The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury

  2017cites this paper
• Humoral and Cellular Immunity Changed after Traumatic Brain Injury in Human Patients.

  2017cites this paper
• Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis

  2017cites this paper
• Transcriptomic analyses reveal cell cycle and complement inhibitors may be specific for treatment of spinal cord injury in aged and young mice *

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Complement in neuroinflammation Bahia

  2017cites this paper
• CIRCULATING AUTOANTIBODIES IN HUMAN TRAUMATIC SPINAL CORD INJURY SUBJECTS AND THEIR RELATIONSHIP TO THE DEVELOPMENT OF NEUROPATHIC PAIN

  2017influential citation
• Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement

  2017cites this paper
• Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.

  2016cites this paper
• Complement activation at the motor end-plates in amyotrophic lateral sclerosis

  2016cites this paper
• Deciphering the role of innate and adaptive immunity following traumatic spinal cord injury: a route to improved outcomes

  2016cites this paper
• When the Microenvironment Talks, Do Neural Stem Cells Listen? Novel Roles for Complement and Immune Interactions in Autocrine Regulation and Paracrine Modulation of Neural Stem Cells

  2016influential citation
• The role of complement in neurological and neuropsychiatric diseases

  2015cites this paper
• The microanatomy of spinal cord injury: A review

  2015cites this paper
• Contemporary Views on the Pathogenesis of Trauma to the Spinal Cord and Peripheral Nerve Trunks

  2015cites this paper
• Towards multiple interactions of inner and outer sensations in corporeal awareness

  2015cites this paper
• PMX53 protects spinal cord from ischemia-reperfusion injury in rats in the short term

  2015cites this paper
• M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator

  2015cites this paper
• The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury

  2015cites this paper
• Neurobiology of Disease Complement Protein C 1 q Modulates Neurite Outgrowth In Vitro and Spinal Cord Axon Regeneration In Vivo

  2015cites this paper
• Complement Protein C1q Modulates Neurite Outgrowth In Vitro and Spinal Cord Axon Regeneration In Vivo

  2015cites this paper
• Characterization of recovery, repair, and inflammatory processes following contusion spinal cord injury in old female rats: is age a limitation?

  2014cites this paper
• Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment.

  2014influential citation
• CSF Proteomics of Secondary Phase Spinal Cord Injury in Human Subjects: Perturbed Molecular Pathways Post Injury

  2014cites this paper
• Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.

  2014cites this paper
• Molecular and Cellular Changes in the Lumbar Spinal Cord following Thoracic Injury: Regulation by Treadmill Locomotor Training

  2014cites this paper
• Synergistic actions of olomoucine and bone morphogenetic protein-4 in axonal repair after acute spinal cord contusion

  2014cites this paper
• Injury to the Spinal Cord Niche Alters the Engraftment Dynamics of Human Neural Stem Cells

  2014cites this paper
• Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury model

  2013cites this paper
• Host Responses to Human Neural Cell Therapy in Spinal Cord Injury

  2013cites this paper
• Innate immune network in the retina activated by optic nerve crush.

  2013cites this paper
• Safety of Human Neural Stem Cell Transplantation in Chronic Spinal Cord Injury

  2013cites this paper
• The Terminal Pathway of the Complement System Is Activated in Focal Penetrating But Not in Mild Diffuse Traumatic Brain Injury

  2013cites this paper
• Host responses to human neural cell therapy in spinal cord injury

  2013cites this paper
• Human Neural Stem Cells for Spinal Cord Injury Therapy Safety of Epicenter Versus Intact Parenchyma as a Transplantation Site for

  2013cites this paper
• Combined transplantation of GDAsBMP and hr-decorin in spinal cord contusion repair

  2013cites this paper
• Examining the Regulation of Inflammation through CD200 and CD200R Following Spinal Cord Injury

  2013cites this paper
• Genetic Networks Activated by Blast Injury to the Eye

  2013cites this paper
• Attenuation of Spinal Cord Injury-Induced Astroglial and Microglial Activation by Repetitive Transcranial Magnetic Stimulation in Rats

  2013influential citation
• Stem cell-based treatments for spinal cord injury.

  2012cites this paper
• Blast-induced moderate neurotrauma (BINT) elicits early complement activation and tumor necrosis factor α (TNFα) release in a rat brain.

  2012cites this paper
• Central nervous system distribution of the poxviral proteins after intranasal administration of proteins and titering of vaccinia virus in the brain after intracranial administration.

  2012cites this paper
• Traumatic brain injury in humans and animal models

  2012cites this paper
• Complement activation in the injured central nervous system: another dual-edged sword?

  2012influential citation
• Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications.

  2012cites this paper
• Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system

  2012cites this paper
• Expression of inflammatory cytokines following acute spinal cord injury in a rodent model

  2012influential citation
• Review of the BCI Competition IV

  2012cites this paper
• Curcumin prevents toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity in rats

  2011cites this paper
• Ghrelin inhibits hydrogen peroxide-induced apoptotic cell death of oligodendrocytes via ERK and p38MAPK signaling.

  2011cites this paper
• Effects of axon degeneration on oligodendrocyte lineage cells: Dorsal rhizotomy evokes a repair response while axon degeneration rostral to spinal contusion induces both repair and apoptosis

  2010cites this paper
• The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

  2010cites this paper
• Effects of C3 deficiency on inflammation and regeneration following spinal cord injury in mice.

  2010cites this paper
• The effects of parenteral or dietary omega-3 polyunsaturated fatty acids in rat models of spinal cord injury

  2010cites this paper
• Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

  2010cites this paper
• Commentary Targeted Modulation of the Neuroinflammatory Response after Spinal Cord Injury

  2010cites this paper
• Intrinsic and Extrinsic Factors for the Regeneration of Brainstem Axons after Spinal Cord Injury

  2010cites this paper
• Soluble complement receptor type 1 inhibits complement system activation and improves motor function in acute spinal cord injury

  2010cites this paper
• Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".

  2010cites this paper
• Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

  2009cites this paper
• Innate immunity in the nervous system.

  2009cites this paper
• Ephedra sinica inhibits complement activation and improves the motor functions after spinal cord injury in rats.

  2009cites this paper
• B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice.

  2009cites this paper
• Title Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury

  2008influential citation